Akums gets DCGI nod for triple combination diabetes medication
Sitagliptin 100, Pioglitazone 15 and Metformin 1000/500 have been combined for the treatment of diabetes and offers a number of pharmacological advantages, the company said in a statement.
The combination drug is going to better serve anti-diabetic patients, who require better treatment without necessarily swallowing multiple drugs. Image Credit: Pixabay/file